Rx Medicare

BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, announced results of a new pilot clinical study on use of the company’s Allay? product for the treatment of menstrual pain. In a study conducted by Dr. Barry Eppley, 23 female patients (ages 19 to 37) with problematic menstrual issues used the Allay patch continuously for five days when the onset of their menstrual period was evident.

Read More…

Related Posts

• BioElectronics Completes Menstrual Pain Clinical Study
• BioElectronics Announces Menstrual Pain Clinical Study – Further Examining Use Of PEMF To Reduce Menstrual Pain
• China Aoxing Pharmaceutical Company Announces Successful Completion Of Phase II Clinical Study Of Novel Menstrual Pain Drug
• BioElectronics Announces Results From Pilot Section Of Acetaminophen Comparative Study
• Baxter Presents Clinical Efficacy Results From Phase III Study Of Seasonal Flu Vaccine
• Clinical Study: Biologic Grafts Reduce Postoperative Pain While Creating A Repair As Durable As Synthetic Mesh In Treating Inguinal Hernias
• SciClone And Sigma-Tau Announce Additional Positive Results In Clinical Study Examining ZADAXIN’s Ability To Enhance Response To H1N1 Vaccine
• Introducing an online community into a clinical education setting: a pilot study of student and staff engagement and outcomes using blended learning
• SciClone And Sigma-Tau Announce Positive Preliminary Results In Clinical Study Examining ZADAXIN’S Ability To Enhance Response To H1N1 Vaccine
• SinoFresh Nasal Spray Achieves Positive Results Against H1N1 (Swine Flu) Virus In Initial Pilot Animal Study
• BioElectronics Technology More Effective Than Extra Strength Tylenol(R) In Reducing Muscle Soreness In Clinical Study
• Transdel Pharmaceuticals Announces Positive Phase 3 Study Results For Lead Topical Pain Drug Ketotransdel(R)
• BioElectronics Announces Completion Of Clinical Study — Preparing FDA 510(K) Pre-Marketing Notification For OTC Clearance
• AcelRx Announces Positive Phase 2 Results From A Study Of ARX-01 Sufentanil NanoTabs In Treating Post-Operative Pain
• Competitive Technologies’ Pain Therapy Medical Device To Be Used In Independent Clinical Study

Tags: bioelectronics, clinical, menstrual, pain, pilot, results, study

This entry was posted on Thursday, February 5th, 2009 at 4:02 am and is filed under Analgesics Pain Migraine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.